A fast and cheap method of producing a promising antibiotic that could treat superbugs has been developed for the first time.
Researchers at the University of Bristol, England, hope their work will help towards finding an urgently needed strain of antibiotics that are cost effective and can tackle infections such as drug-resistant tuberculosis (XTB).
They expressed the genes involved in the antibiotic pleuromutilin, which are isolated from the mushroom Clitopilus passeckerianus, and placed them in a different type of fungus, thereby increasing production by more than 2,000%.
Working with pharmaceutical company GSK, the Bristol scientists identified the genes involved in the production of pleuromutilin and found that a seven-gene cluster is needed to produce the antibiotic in C. passeckerianus.
The cluster was reconstructed within a more industrial fungus, Aspergillus oryzae, which belongs to the ascomycetes family of fungi, resulting in an increased production of 2,106%.
It is the first gene cluster from a basidiomycete to be expressed successfully in an ascomycete, and it paves the way a metabolically rich but traditionally overlooked group of fungi to be used.
Co-author of the research, Professor Gary Foster said: “This was a massive team effort over many years to achieve this major breakthrough. With this development, we are now ideally placed to develop novel derivatives and new antibiotics and produce them rapidly and cost effectively – something which is desperately needed globally.”
Bailey A, Alberti F, Kilaru S et al. Identification and manipulation of the pleuromutilin gene cluster from Clitopilus passeckerianus for increased rapid antibiotic production. Scientific Reports 4 May 2016 [abstract]

Leave a Reply